The total market value of Contrast Media Injectors expected to be sold this year, 2023, is estimated to be around US$ 1.6 billion. Furthermore, the global contrast media injector market is expected to reach approximately US$ 3 billion by 2033, with a 6.6% annual growth rate. Increasing trauma cases globally is expected to boost the …
Category Archives: Healthcare Trends
General Anesthesia Drugs Market is expected to reach a valuation of US$ 6.7 Billion, with sales revenue anticipated to grow at 3.4% CAGR by 2032 | FMI
The general General Anesthesia Drugs Market is anticipated to reach a value of US$ 4.7 billion by the end of 2022 and to grow at a CAGR of 3.4% to US$ 6.7 billion by 2032. Propofol is the most popular drug class right now, with a market share of about 25.6% in 2021, according to …
Pelvic Floor Stimulators Market is reaching US$ 274.9 Million by 2031
Increasing demand for electrical stimulation to treat urinary incontinence is expected to boost the global pelvic floor stimulator market. Global sales of pelvic floor stimulators are expected to reach US$ 118.6 Million in 2021, according to Future Market Insights’ (FMI) recently published analysis of the pelvic floor stimulators market. The market’s demand outlook is still promising, …
Continue reading “Pelvic Floor Stimulators Market is reaching US$ 274.9 Million by 2031”
Poultry Diagnostics Market is expected a revenue growth of US$ 1.6 billion by 2033
The Global Poultry Diagnostics Market is projected to have a moderate-paced CAGR of 10.5% during the forecast period. The current valuation of the poultry diagnostics market is US$ 590 million in 2023. The value of the poultry diagnostics market is anticipated to reach US$ 1.6 billion, by the year 2033. Over the foreseeable years, the poultry diagnostics …
Foley Catheter Market is anticipated to CAGR of 5.4% by 2033
The global foley catheter market is projected to be worth US$1,565 million. The market is expected to grow at a CAGR of 5.4% from 2023 to 2033, reaching US$ 2,641 million. The foley catheter industry has been witnessing steady growth in recent years due to the rising incidence of urological disorders such as urinary incontinence, bladder retention, …
Continue reading “Foley Catheter Market is anticipated to CAGR of 5.4% by 2033”
Sandhoff Disease Therapeutics Market is expected to reach US$ 17.91 Million by 2033, at a CAGR of 6%
The global Sandhoff Disease Therapeutics Market is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent research, Sandhoff illness is a …
Helicobacter Pylori Infections Treatment Market is expected to garner a value of US$ 1,260 Million by 2033
By 2023, the global market for treating Helicobacter pylori infections is forecasted to achieve a worth of US$ 638.3 million, with a projected compound annual growth rate (CAGR) of 7.04% from 2023 to 2033, leading to a total value of US$ 1,260 million. The spread of this infection can be attributed to several factors, such …
PD1 Resistant Head and Neck Cancer Market is expected to reach US$ 5 billion by 2033, at a CAGR of 12.5%
In 2023, the global PD1 resistant head and neck cancer market size is projected to reach a value of US$ 1.54 billion and is anticipated to reach US$ 5 billion by 2033, exhibiting a CAGR of 12.5%. The increasing geriatric population and initiatives by government and non-governmental organizations such as Support for People with Oral …
Pollen Allergy Market Share 2023 to 2033 | By bioMerieux SA, HOB Biotech, Alcon, HYCOR Biomedical
The global pollen allergy market is now estimated at US$ 5850.8 million in 2023 and is expected to grow at a 4.2% CAGR. Because to technology advancements in healthcare, the market is expected to reach US$ 8828.6 million by 2033. The rise in the number of people suffering from pollen-based allergies, including hay fever, drives …
Anxiety Disorders and Depression Treatment Market in Europe to Scale New Heights; U.K to yield a US$ Opportunity worth 141.2 Million
Europe is predicted to be the second-largest participant in the anxiety disorders and depression treatment market, owing to major investments in R&D for the advancement of antidepressant medications. This, together with rising sales of anxiety-related products, is expected to drive growth throughout the projection period. The government’s goal of minimising the financial burden of these …